Filter
Sort
At a recent virtual town hall, leaders of the Pacific Northwest RECOVER hub shared what they’ve learned so far about long COVID — from symptom trajectories and genetic risk to early trial results and upcoming studies — and answered questions from participants about risk factors, persistent symptoms and what comes next.
Discussing Super Agers, Drs. Eric Topol and Lee Hood connected breakthroughs in genomics, AI, and lifestyle science to the pursuit of longer, healthier lives.
The pioneering work of Mary Brunkow and Fred Ramsdell began with a mysterious mutant mouse known as “scurfy,” leading them to identify the FOXP3 gene and unlock how regulatory T cells prevent autoimmune disease — discoveries that now point to new treatments in cancer and autoimmunity.
The prize recognizes foundational discoveries about regulatory T cells and the FOXP3 gene that redefined immune tolerance and opened avenues to treat autoimmune disease, enable transplantation, and advance immuno-oncology. ISB celebrates Dr. Brunkow’s leadership and collaborative science.
ISB honors Dr. Charles “Chuck” Watts (1942–2025) – physician, leader, and former Board Chair – who died on September 23 after a battle with esophageal cancer. A champion of patient safety, systems biology, and STEM education, Chuck guided ISB with insight and warmth. His legacy endures in our mission and community.
ISB Co-founder Dr. Leroy (Lee) Hood has been named one of the inaugural recipients of the Michael Sela Prize in Biomedical Sciences, awarded by the Weizmann Institute of Science. Hood shares the honor with Dr. Francis S. Collins and Dr. Eric S. Lander for pioneering work that has reshaped modern medicine and advanced human health.